Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/7519
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNorbekova M. X., Fayziev F. Sh.-
dc.date.accessioned2023-05-07T09:38:59Z-
dc.date.available2023-05-07T09:38:59Z-
dc.date.issued2023-
dc.identifier.urihttp://repository.tma.uz/xmlui/handle/1/7519-
dc.description.abstractA significant number of scientific papers have been devoted to breast cancer in the female population, while insufficient attention has been paid to cancer and dyshormonal diseases of the mammary glands in men. Nevertheless, this issue is becoming more urgent every year. Although breast cancer in men is a relatively rare disease (1-2% of the number of these tumors in women), it is not inferior to “female” cancer in terms of malignancy, and sometimes even surpasses it. Changes in the mammary gland in men are primarily associated with hormonal imbalance, the manifestation of which is gynecomastia. Until now, there is no consensus on the relationship between gynecomastia and breast cancer, although it has been established that the incidence of malignant tumors against the background of gynecomastia makes up 3.9 - 40.0% of casesen_US
dc.language.isoen_USen_US
dc.publisherAmerican Journal of Medicine and Medical Sciencesen_US
dc.subjectBreast cancer, Gynecomastia, Oncoepidemiology, Hormone therapyen_US
dc.titleClinical and Epidemiological Features of Dishormonal Diseases and Breast Cancer in Men in the Aral Sea Regionen_US
dc.typeArticleen_US
Appears in Collections:Thesis, Articles

Files in This Item:
File Description SizeFormat 
American Journal of Medicine and Medical Sciences 2023.pdfClinical and Epidemiological Features of Dishormonal Diseases and Breast Cancer in Men in the Aral Sea Region361.91 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.